Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W T Beck

Showing results (21-30 of 103) with videos related to

Pageof 11
Sort By:
Cancer Treatment Reports|June 1, 1984
Acquisition of multiple drug resistance by CCRF-CEM cells selected for different degrees of resistance to vincristineV Conter, W T Beck
Oncology Research|January 1, 1997
Heterogeneous expression of DNA topoisomerase II alpha isoforms in tumor cell linesY Y Mo, W T Beck
Cancer Research|January 1, 1982
Continued expression of vinca alkaloid resistance by CCRF-CEM cells after treatment with tunicamycin or pronaseW T Beck, M C Cirtain
Biochemical and Biophysical Research Communications|September 16, 1980
Administration of queuine to mice relieves modified nucleoside queuosine deficiency in Ehrlich ascites tumor tRNAJ R Katze, W T Beck
Lancet (London, England)|August 22, 1992
Neurological symptoms associated with cyclosporin plus doxorubicinW T Beck, J F Kuttesch
Molecular Pharmacology|February 13, 2001
Role of an inverted CCAAT element in human topoisomerase IIalpha gene expression in ICRF-187-sensitive and -resistant CEM leukemic cellsS E Morgan, W T Beck
Leukemia|July 1, 1997
Methods to detect P-glycoprotein and implications for other drug resistance-associated proteinsW T Beck, T M Grogan
Experimental Cell Research|September 30, 1999
Association of human DNA topoisomerase IIalpha with mitotic chromosomes in mammalian cells is independent of its catalytic activityY Y Mo, W T Beck
Biochemical Pharmacology|January 9, 1992
Photoaffinity substrates for P-glycoproteinW T Beck, X D Qian
Biochemical Pharmacology|December 1, 1986
Chloroquine enhancement of anticancer drug cytotoxicity in multiple drug resistant human leukemic cellsJ M Zamora, W T Beck
Pageof 11

Showing results (21-30 of 103) with videos related to

Sort By:
Pageof 11
Cancer Treatment Reports|June 1, 1984
Acquisition of multiple drug resistance by CCRF-CEM cells selected for different degrees of resistance to vincristineV Conter, W T Beck
Oncology Research|January 1, 1997
Heterogeneous expression of DNA topoisomerase II alpha isoforms in tumor cell linesY Y Mo, W T Beck
Cancer Research|January 1, 1982
Continued expression of vinca alkaloid resistance by CCRF-CEM cells after treatment with tunicamycin or pronaseW T Beck, M C Cirtain
Biochemical and Biophysical Research Communications|September 16, 1980
Administration of queuine to mice relieves modified nucleoside queuosine deficiency in Ehrlich ascites tumor tRNAJ R Katze, W T Beck
Lancet (London, England)|August 22, 1992
Neurological symptoms associated with cyclosporin plus doxorubicinW T Beck, J F Kuttesch
Molecular Pharmacology|February 13, 2001
Role of an inverted CCAAT element in human topoisomerase IIalpha gene expression in ICRF-187-sensitive and -resistant CEM leukemic cellsS E Morgan, W T Beck
Leukemia|July 1, 1997
Methods to detect P-glycoprotein and implications for other drug resistance-associated proteinsW T Beck, T M Grogan
Experimental Cell Research|September 30, 1999
Association of human DNA topoisomerase IIalpha with mitotic chromosomes in mammalian cells is independent of its catalytic activityY Y Mo, W T Beck
Biochemical Pharmacology|January 9, 1992
Photoaffinity substrates for P-glycoproteinW T Beck, X D Qian
Biochemical Pharmacology|December 1, 1986
Chloroquine enhancement of anticancer drug cytotoxicity in multiple drug resistant human leukemic cellsJ M Zamora, W T Beck
Pageof 11